Indigo Medical's laser cleared for general surgery:
This article was originally published in Clinica
Executive Summary
Indigo Medical's portable 830 diode laser system has been cleared by the US FDA for use in general surgery and urological and gastroenterological procedures. Six-month follow-up of 100 patients treated with the laser for benign prostatic hyperplasia is under way in preparation for 510(k) clearance. The system, which is CE-marked, is already marketed for BPH treatment outside the US through Indigo's German and Hong Kong subsidiaries (see Clinica No 672, p 18).
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.